Compartilhar
Informação da revista
Vol. 46. Núm. S4.
HEMO 2024
Páginas S349-S350 (outubro 2024)
Vol. 46. Núm. S4.
HEMO 2024
Páginas S349-S350 (outubro 2024)
Acesso de texto completo
A NOVEL IN VITRO BONE MARROW NICHE PLATFORM FOR INVESTIGATING THERAPEUTIC STRATEGIES FOR ACUTE LEUKEMIAS
Visitas
357
DP Echevarriaa,b,c, MLP Buenoa, I Santosa, NG Amôra, FM Roversia,d, AN Brunoc, STO Saada
a Centro de Hematologia e Medicina Transfusional (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
b Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
c Instituto Federal de Educação Ciência e Tecnologia do Rio Grande do Sul (IFRS), Porto Alegre, Brazil
d Department of Surgery Division of Transplantation, Emory University, Atlanta, United States
Este item recebeu
Informação do artigo
Suplemento especial
Este artigo faz parte de:
Vol. 46. Núm S4

HEMO 2024

Mais dados
Aims

Acute lymphoblastic leukemia (ALL), the most prevalent childhood cancer, disrupts the hematopoietic bone marrow (BM) niche, a specialized microenvironment that supports normal hematopoiesis. During ALL development, this niche undergoes remodeling and reprogramming to support tumor growth, hindering blood cell formation. Mesenchymal stromal cells (MSCs), particularly those located in the perivascular niche, play a pivotal role by shielding leukemic lymphoblasts from external stressors, impacting drug responses and potentially contributing to relapse. Understanding this complex interplay between ALL cells and the BM niche is vital for developing effective drug screening models. Therefore, our study aimed to develop an in vitro coculture system that mimics the ALL BM tumor microenvironment.

Methods

T-ALL (Jurkat), B-ALL (RS4-11), and MSCs (HS5) cell lines were maintained in RPMI-1640 supplemented with 10% FBS. Tridimensional cocultures were established using hemostatic sponges (Gelfoam, Pfizer) and spheroids (Hanging Drop or Liquid Overlay Technique containing 0, 5, 10 and 20% Matrigel). These cocultures combined normal MSCs (HS5) and ALL cells to mimic different cellular environments within the tumor microenvironment. Different cell ratios (MSC to T-ALL proportion: 1:1, 1:2, 1:5, 2:5) were tested to simulate different cellular environments. To evaluate the system's applicability, the cocultures were treated for 72h with a BCL2 inhibitor, Venetoclax, or an MCL1 inhibitor, AZD5991, as single agents or in combination. Both agents were used at their 10% maximal response concentration (IC10 - 20 nM). Following the treatment, the 3D systems were dissociated using collagenase (for Gelfoam) or trypsin (for spheroids), and cell populations were analyzed by flow cytometry.

Results

In comparison to monocultures, T-ALL cell viability was enhanced in cocultures with MSCs in Gelfoam 3D system, with ̃80% of viable ALL cells in all cell ratios tested. Conversely, proliferation of MSCs was diminished compared to monocultures. Although spheroid formation was obtained using hanging drop technique, increasing Matrigel concentrations impaired spheroid formation, except at the highest cell seeding ratio (2:5), which still resulted in highly irregular spheroids with a near-equal distribution of ALL cells and MSCs (1:1). Thus, considering the bone marrow microenvironment, Gelfoam (1:5 cell ratio) was the 3D system that most closely resembled the cellular composition observed in ALL. Cocultures in Gelfoam were treated with Venetoclax and/or AZD5991. The combination therapy effectively inhibited the proliferation of ALL cells in monoculture. However, the combined treatment was not enough to overcome the protective niche action. Importantly, the treatments did not affect MSCs proliferation.

Conclusions

Our findings demonstrate an innovative 3D coculture system that successfully replicates the BM stromal niche. This novel platform holds promise for the development of new therapeutic strategies for ALL.

Apoio

FAPESP 2017/21801-2, 2019/25247-5, 2021/05320-0; 2023/13850-4; CNPq 303405/2018-0.

O texto completo está disponível em PDF
Baixar PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas